Penehyclidine for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Laparoscopic Surgery Under Combined Intravenous and Inhalation Anesthesia: A Randomized, Double-Blind, Placebo-Controlled Trial [Letter]
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s482220 ↗Kurz gefasst
Leserbrief in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Muhammed Halit Satici. Beteiligte Einrichtung: University of Health Sciences, Konya City Hospital Department of Anesthesiology and Reanimation, Konya, Turkey. Hauptthemen laut MEDLINE: Gynecologic Surgical Procedures, Laparoscopy, Postoperative Nausea and Vomiting, Quinuclidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Health Sciences, Konya City Hospital Department of Anesthesiology and Reanimation, Konya, Turkey.
ORCID-Profile: Muhammed Halit Satici
Zitieren
APA
Satici, M. H. (2024). Penehyclidine for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Laparoscopic Surgery Under Combined Intravenous and Inhalation Anesthesia: A Randomized, Double-Blind, Placebo-Controlled Trial [Letter]. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s482220
Vancouver
Satici MH. Penehyclidine for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Laparoscopic Surgery Under Combined Intravenous and Inhalation Anesthesia: A Randomized, Double-Blind, Placebo-Controlled Trial [Letter]. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s482220
BibTeX
@article{Satici2024,
author = {Satici, Muhammed Halit},
title = {Penehyclidine for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Laparoscopic Surgery Under Combined Intravenous and Inhalation Anesthesia: A Randomized, Double-Blind, Placebo-Controlled Trial [Letter]},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s482220}
}
EUVIMED